InspireMD (NSPR) News Today $2.53 +0.25 (+10.96%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.44 -0.09 (-3.56%) As of 05/23/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock NSPR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period InspireMD (NYSE:NSPR) versus OrthoPediatrics (NASDAQ:KIDS) Head-To-Head ReviewMay 18, 2025 | americanbankingnews.comParkman Healthcare Partners LLC Has $2.25 Million Stock Holdings in InspireMD, Inc. (NYSE:NSPR)Parkman Healthcare Partners LLC lifted its holdings in InspireMD, Inc. (NYSE:NSPR - Free Report) by 721.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 854,716 shares of the company's stock after purchasing an additional 750,635 shares during the quarter.May 16, 2025 | marketbeat.comInspireMD at Bank of America 2025: Carotid Stent InnovationMay 15, 2025 | uk.investing.comPiper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00Piper Sandler reduced their target price on shares of InspireMD from $4.50 to $4.00 and set an "overweight" rating for the company in a research note on Monday.May 14, 2025 | marketbeat.comEarnings call transcript: InspireMD Q1 2025 shows mixed resultsMay 11, 2025 | uk.investing.comInspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent SystemMay 11, 2025 | nasdaq.comInspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call TranscriptMay 10, 2025 | insidermonkey.comInspireMD Inc.: InspireMD Reports First Quarter 2025 Financial ResultsMay 9, 2025 | finanznachrichten.deINSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and MoreMay 9, 2025 | nasdaq.comInspireMD Q1 2025 Earnings PreviewMay 9, 2025 | msn.com4NSPR : A Look Ahead: InspireMD's Earnings ForecastMay 9, 2025 | benzinga.comInspireMD, Inc. (NSPR) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comInspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is OptimisticMay 9, 2025 | msn.comInspireMD Reports First Quarter 2025 Financial ResultsMay 9, 2025 | globenewswire.comInspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.comStockNews.com assumed coverage on shares of InspireMD in a research report on Monday. They issued a "sell" rating on the stock.May 6, 2025 | marketbeat.comInspireMD to Present at Upcoming Bank of America 2025 Healthcare ConferenceApril 30, 2025 | globenewswire.comNantahala Capital Management LLC Trims Stock Holdings in InspireMD, Inc. (NYSE:NSPR)Nantahala Capital Management LLC reduced its stake in InspireMD, Inc. (NYSE:NSPR - Free Report) by 24.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,674,565 shares of the company's stock afteApril 30, 2025 | marketbeat.comInspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.comStockNews.com started coverage on shares of InspireMD in a research report on Sunday. They set a "sell" rating for the company.April 28, 2025 | marketbeat.comInspireMD to Announce First Quarter 2025 Financial ResultsApril 25, 2025 | globenewswire.comStockNews.com Begins Coverage on InspireMD (NYSE:NSPR)StockNews.com assumed coverage on InspireMD in a report on Saturday. They set a "sell" rating on the stock.April 20, 2025 | marketbeat.comStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)StockNews.com began coverage on shares of InspireMD in a research note on Friday. They set a "sell" rating for the company.April 13, 2025 | marketbeat.comInspireMD Inc.: InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 | finanznachrichten.deInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 | globenewswire.comInspireMD files $200M mixed securities shelfApril 2, 2025 | markets.businessinsider.comInspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare ConferenceMarch 26, 2025 | globenewswire.comInspireMD (NYSE:NSPR) Coverage Initiated at StockNews.comStockNews.com began coverage on InspireMD in a research report on Wednesday. They set a "sell" rating on the stock.March 26, 2025 | marketbeat.comInspireMD, Inc. (NASDAQ:NSPR) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | msn.comInspireMD, Inc. (NSPR) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comInspireMD reports Q4 EPS (19c) vs (16c) last yearMarch 12, 2025 | markets.businessinsider.comInspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue EstimatesMarch 12, 2025 | msn.comInspireMD Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 12, 2025 | globenewswire.comNuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised)March 11, 2025 | msn.comLake Street Remains a Buy on InspireMD (NSPR)March 10, 2025 | markets.businessinsider.comInspireMD (NYSE:NSPR) Now Covered by StockNews.comStockNews.com began coverage on shares of InspireMD in a research report on Sunday. They set a "sell" rating on the stock.March 2, 2025 | marketbeat.comNSPR stock touches 52-week high at $3.43 amid robust growthFebruary 26, 2025 | investing.comInspireMD to Announce Fourth Quarter and Full Year 2024 Financial ResultsFebruary 26, 2025 | globenewswire.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 25, 2025 | globenewswire.comInvestors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five yearsFebruary 24, 2025 | finance.yahoo.comInspireMD participates in a conference call with Lake StreetFebruary 14, 2025 | markets.businessinsider.comInspireMD, NAMSA partner on CGUARDIANS II trial of CGuard PrimeFebruary 13, 2025 | markets.businessinsider.comInspireMD (NSPR) Receives a Buy from Lake StreetFebruary 13, 2025 | markets.businessinsider.comInspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR proceduresFebruary 13, 2025 | globenewswire.comInspireMD announces inducement grants under Nasdaq listing ruleFebruary 4, 2025 | markets.businessinsider.comInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 4, 2025 | globenewswire.comInspireMD announces inducement grantsJanuary 22, 2025 | markets.businessinsider.comHere's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn SituationJanuary 14, 2025 | finance.yahoo.comInspireMD, Inc.: InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025December 12, 2024 | finanznachrichten.deInspireMD Finance Chief Craig Shore To RetireDecember 12, 2024 | markets.businessinsider.comInspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025December 12, 2024 | finance.yahoo.comLake Street Initiates Coverage of InspireMD (NSPR) with Buy RecommendationDecember 12, 2024 | msn.com Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address NSPR Media Mentions By Week NSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼0.000.75▲Average Medical News Sentiment NSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼11▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZIMV News Today TCMD News Today NYXH News Today NVRO News Today DRTS News Today SKIN News Today CATX News Today BWAY News Today LAKE News Today ELMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Hidden Energy Source Backed by Billionaires Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NSPR Stock Free NSPR Stock Alerts